Skip to main content

Advertisement

SpringerLink
Log in

What level of serum calcitonin indicates medullary thyroid carcinoma in patients with chronic kidney disease?

  • Practice Point
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Leboulleux S et al. (2004) Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61: 299–310

    Article  Google Scholar 

  2. Messa P et al. (1995) The calcitonin–calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Nephrol Dial Transplant 10: 2259–2265

    Article  CAS  Google Scholar 

  3. Karanikas G et al. (2004) Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89: 515–519

    Article  CAS  Google Scholar 

  4. Costante G et al. (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92: 450–455

    Article  CAS  Google Scholar 

  5. Papi G et al. (2006) Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29: 427–437

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Hospital Georges Pompidou, Department of Nephrology, University Paris V, 20 rue Leblanc, Paris 75015, France alain.meyrier@brs.aphp.fr

Authors and Affiliations

  1. A Meyrier is a Senior Nephrologist in the Department of Nephrology at the Hospital Georges Pompidou, University of Paris René Descartes Medical School, Paris, France.,

    Alain Meyrier

Authors
  1. Alain Meyrier
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyrier, A. What level of serum calcitonin indicates medullary thyroid carcinoma in patients with chronic kidney disease?. Nat Rev Nephrol 3, 246–247 (2007). https://doi.org/10.1038/ncpneph0464

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0464

  • Springer Nature Limited

Search

Navigation